TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market August 2, 2002